Interstitial lung disease is a blanket term for a big group of disorders categorized by progressive scarring of both the lung tissue supporting and between the air sacs. This tissue is called the interstitium. The interstitium consists of the region between the alveolar space and the capillaries. The scarring causes inflammation and damage in the lung tissue followed by lung stiffness, meaning the air sacs cannot expand as much as before. Lung stiffness makes it harder to breathe. People affected by the condition are not able to get enough oxygen from the lungs into their bloodstream.
Although some potential causes have been researched, there may be no underlying cause for development of interstitial lung disease. If there is no known cause, it is called idiopathic interstitial lung disease. IPF or idiopathic pulmonary fibrosis remains the most common type of this illness. Of the causes most widely recognized, cigarette smoking is said to potentially make the disease more severe and the progression and onset more rapid. Although there are treatments, once lung scarring begins there is no means of reversing the damage.
Symptoms vary, but generally include a dry cough as well as shortness of breath either from after exertion or at rest. Other symptoms are often restricted to the respiratory tract. The condition is long-term lasting years or for some, can be lifelong. People most affected by the disorder is anyone over the age of 19 with many experiencing it after the age of 60. While it is a rare disorder, there are 200,000 cases reported annually in the United States. When people with a disease that falls within this category undergo physical examination, they will typically have bilateral inspiratory fine crackles. These are seen clearly seen at the lung bases. What should not be expected when examining is expiratory wheezing as it is relatively uncommon. If any skin rashes or joint deformities are present, this may signal underlying connective tissue...
CellCept drug for the treatment of kidney complications could be a boon to lupus patients (Chang, 2005). A small study showed that the drug delivered better results than standard chemotherapy, which could cause infertility and other medical problems. A recent experiment compared the effects of CellCept and the older treatment, cyclophosphamide, in patients for 6 months. Those taking CellCept reported fewer side effects. The researchers were led by Dr. Ellen
The most common cause of death is infection due to immunosuppression, a result in turn of medications intended to manage the disease. Chances are worse for men and children than for women. After the age of 60, the disease tends to turn benign. The only marker of prognosis in lupus is the anti-ds DNA antibody test and the most sensitive is the Anti-Smith test (Wikipedia) The standard treatment for lupus
Systemic Lupus Erythematosus Case Study Systemic Lupus Erythematosus Systemic lupus erythematosus (SLE) is a chronic, life-long autoimmune disease that affects multiple tissues and organs in the body (Madhok and Wu, 2009). The primary tissues and organs affected by immune system dysfunction are the joints, kidneys, vessel walls, and skin. SLE is believed to be due to an interaction between genetic factors and environmental triggers. The disease is also more prevalent among women,
Oral Manifestations of Lupus Erythematosus Oral Manifestations of Lupus Oral Manifestations of Lupus Erythematosis Systemic lupus erythematosus (SLE), or lupus for short, is a chronic and generally progressive autoimmune disease affecting many tissues in the body (Lupus Foundation of America, 2015). The U.S. Centers for Disease Control and Prevention (CDC, 2015) discriminates between SLE and lupus affecting the skin only (discoid/cutaneous lupus erythematosis) or that caused by medications (temporary). SLE and cutaneous lupus
Anti-Smith antigen is observed in 25% of patients with SLE overall, with 10-20% whites and 30-40% blacks and Asians and Lupus erythematosus (LE) preparation is found in most patients with active SLE. Treating the active phase of the disease without allowing the treatment itself to cause long-term damage to the patient is the major challenge for doctors. As a result of this physicians are now less hesitant to use immunosuppressive
Another caution that exists for people suffering from lupus is to exercise caution before and after receiving dental treatment. Lupus patients could develop serious heart infections from the streptococci that might be released into their bloodstream during routine dental procedures, even bi-annual teeth cleanings (Blau and Schultz, 174). The infection can travel to the heart when the patient has certain other manifestations of lupus, and, if the patient has developed
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now